Literature DB >> 20816889

Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.

John R Mantsch1, Samantha Wisniewski, Oliver Vranjkovic, Corey Peters, Amanda Becker, Abbey Valentine, Shi-Jiang Li, David A Baker, Zheng Yang.   

Abstract

Levo-tetrahydropalmatine (l-THP) is an alkaloid found in many traditional Chinese herbal preparations and has a unique pharmacological profile that includes dopamine receptor antagonism. Previously we demonstrated that l-THP attenuates fixed-ratio (FR) cocaine self-administration (SA) and cocaine-induced reinstatement in rats at doses that do not alter food-reinforced responding. This study examined the effects of l-THP on cocaine and food SA under progressive-ratio (PR) schedules of reinforcement and the discriminative stimulus effects of cocaine. In adult male Sprague-Dawley rats self-administering cocaine (0.5 or 1.0mg/kg/inf), l-THP significantly reduced breaking points at the 1.875, 3.75 and 7.5mg/kg doses. l-THP also reduced the breaking point and response rate for PR SA of sucrose-sweetened food pellets, although the decrease was significant only at the 7.5mg/kg l-THP dose. In rats trained to discriminate cocaine (10mg/kg, ip) from saline, l-THP (1.875, 3.75 and 7.5mg/kg) produced a rightward shift in the dose-response curve for cocaine generalization. During generalization testing, l-THP reduced response rate, but only at the 7.5mg/kg dose. l-THP also prevented substitution of the dopamine D2/D3 receptor agonist, (±) 7-OH-DPAT, for cocaine suggesting a potential role for antagonism of D2 and/or D3 receptors in the effects of l-THP. These data further demonstrate that l-THP attenuates the reinforcing and subjective effects of cocaine at doses that do not produce marked motor effects and provide additional evidence that l-THP may have utility for the management of cocaine addiction.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816889      PMCID: PMC2956862          DOI: 10.1016/j.pbb.2010.08.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  55 in total

1.  The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered.

Authors:  P M Beardsley; P Sokoloff; R L Balster; J C Schwartz
Journal:  Behav Pharmacol       Date:  2001-02       Impact factor: 2.293

2.  The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Zheng-Xiong Xi; Amy Hauck Newman; Jeremy G Gilbert; Arlene C Pak; Xiao-Qing Peng; Charles R Ashby; Leah Gitajn; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

3.  l-tetrahydropalmatine increases leucine enkephalin levels in corpus striatum of rats.

Authors:  X Z Zhu; Z Zhou; X Q Ji; J Gu; L G Luo; F S Wang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1991-03

Review 4.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Authors:  S M Anderson; R C Pierce
Journal:  Pharmacol Ther       Date:  2005-02-26       Impact factor: 12.310

5.  Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

Authors:  R Y Depoortere; D H Li; J D Lane; M W Emmett-Oglesby
Journal:  Pharmacol Biochem Behav       Date:  1993-07       Impact factor: 3.533

6.  Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.

Authors:  Allison L Chausmer; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2001-09-22       Impact factor: 4.530

7.  Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum.

Authors:  X Guo; L M Wang; J Liu; G Z Jin
Journal:  Zhongguo Yao Li Xue Bao       Date:  1997-05

8.  Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration of the racemate.

Authors:  Zhanying Hong; Guorong Fan; Jian Le; Yifeng Chai; Xueping Yin; Yutian Wu
Journal:  Biopharm Drug Dispos       Date:  2006-04       Impact factor: 1.627

9.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

10.  Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.

Authors:  John R Mantsch; Shi-Jiang Li; Robert Risinger; Sarah Awad; Eric Katz; David A Baker; Zheng Yang
Journal:  Psychopharmacology (Berl)       Date:  2007-03-15       Impact factor: 4.415

View more
  17 in total

Review 1.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 2.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

4.  Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.

Authors:  Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

5.  Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.

Authors:  Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-20       Impact factor: 3.205

6.  Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.

Authors:  Taehyun Kim; David J Hinton; Sandy Johng; Jia Bei Wang; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

7.  Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Hazem E Hassan; Deanna Kelly; Moshe Honick; Sagar Shukla; Ahmed Ibrahim; David A Gorelick; Matthew Glassman; Robert P McMahon; Heidi J Wehring; Ann Marie Kearns; Stephanie Feldman; Mingming Yu; Ken Bauer; Jia Bei Wang
Journal:  J Clin Pharmacol       Date:  2016-08-04       Impact factor: 3.126

8.  Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.

Authors:  Sudharshan Madapa; Satishkumar Gadhiya; Thomas Kurtzman; Ian L Alberts; Steven Ramsey; Maarten Reith; Wayne W Harding
Journal:  Eur J Med Chem       Date:  2016-09-14       Impact factor: 6.514

9.  L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.

Authors:  Wei Xu; Yujun Wang; Zhongze Ma; Yi-Ting Chiu; Peng Huang; Khampaseuth Rasakham; Ellen Unterwald; David Y-W Lee; Lee-Yuan Liu-Chen
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

10.  (-)-Stepholidine blocks expression, but not development, of cocaine conditioned place preference in rats.

Authors:  A Bennett; E Barrera; H Namballa; W Harding; R Ranaldi
Journal:  Neurosci Lett       Date:  2020-06-09       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.